Perfil
Frédéric Dumais is currently the Director of Communications & Investor Relations at ChitogenX, Inc., Director of Communications & Investor Relations at Valeo Pharma, Inc., and a Member of the Québec Bar Association.
In the past, he held positions as Director of Communications & Investor Relations at Liminal BioSciences, Inc., Vice President of Investor Relations at LAB International, Inc. and Akela Pharma, Inc., and Head of Investor Relations at Janssen Pharmaceutica NV.
Cargos activos de Frédéric Dumais
| Empresas | Cargo | Inicio |
|---|---|---|
| VALEO PHARMA INC. | Contacto de Relaciones con Inversores | 01/06/2019 |
| CHITOGENX INC. | Contacto de Relaciones con Inversores | 01/06/2019 |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Frédéric Dumais.
| Empresas | Cargo | Fin |
|---|---|---|
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Public Communications Contact | 13/07/2007 |
| LIMINAL BIOSCIENCES INC. | Contacto de Relaciones con Inversores | - |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Contacto de Relaciones con Inversores | - |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Public Communications Contact | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Liminal BioSciences, Inc.
Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Health Technology |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Finance |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
ChitogenX, Inc.
ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
Valeo Pharma, Inc.
Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
- Bolsa de valores
- Insiders
- Frédéric Dumais
















